1. Home
  2. SSP vs IPHA Comparison

SSP vs IPHA Comparison

Compare SSP & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • IPHA
  • Stock Information
  • Founded
  • SSP 1878
  • IPHA 1999
  • Country
  • SSP United States
  • IPHA France
  • Employees
  • SSP N/A
  • IPHA N/A
  • Industry
  • SSP Broadcasting
  • IPHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSP Industrials
  • IPHA Health Care
  • Exchange
  • SSP Nasdaq
  • IPHA Nasdaq
  • Market Cap
  • SSP 198.7M
  • IPHA 160.1M
  • IPO Year
  • SSP 1988
  • IPHA 2019
  • Fundamental
  • Price
  • SSP $2.08
  • IPHA $2.03
  • Analyst Decision
  • SSP Buy
  • IPHA Strong Buy
  • Analyst Count
  • SSP 2
  • IPHA 1
  • Target Price
  • SSP $6.25
  • IPHA $11.00
  • AVG Volume (30 Days)
  • SSP 957.5K
  • IPHA 27.3K
  • Earning Date
  • SSP 05-08-2025
  • IPHA 03-27-2025
  • Dividend Yield
  • SSP N/A
  • IPHA N/A
  • EPS Growth
  • SSP N/A
  • IPHA N/A
  • EPS
  • SSP 1.01
  • IPHA N/A
  • Revenue
  • SSP $2,509,772,000.00
  • IPHA $20,831,349.00
  • Revenue This Year
  • SSP N/A
  • IPHA $209.83
  • Revenue Next Year
  • SSP $9.18
  • IPHA $83.96
  • P/E Ratio
  • SSP $2.06
  • IPHA N/A
  • Revenue Growth
  • SSP 9.46
  • IPHA N/A
  • 52 Week Low
  • SSP $1.36
  • IPHA $1.29
  • 52 Week High
  • SSP $4.65
  • IPHA $3.51
  • Technical
  • Relative Strength Index (RSI)
  • SSP 41.91
  • IPHA 56.76
  • Support Level
  • SSP $2.01
  • IPHA $1.84
  • Resistance Level
  • SSP $2.29
  • IPHA $2.19
  • Average True Range (ATR)
  • SSP 0.20
  • IPHA 0.11
  • MACD
  • SSP -0.04
  • IPHA 0.02
  • Stochastic Oscillator
  • SSP 8.16
  • IPHA 67.94

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: